These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 8091895

  • 1. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction.
    Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D.
    Acta Cytol; 1994; 38(5):671-5. PubMed ID: 8091895
    [Abstract] [Full Text] [Related]

  • 2. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.
    Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA.
    Am J Pathol; 1995 Mar; 146(3):620-5. PubMed ID: 7887444
    [Abstract] [Full Text] [Related]

  • 3. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z, Gnarra JR, Dudley CF, Zbar B, Linehan WM, Lubensky IA.
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [Abstract] [Full Text] [Related]

  • 4. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.
    Beaty MW, Zhuang Z, Park WS, Emmert-Buck MR, Linehan WM, Lubensky IA, Abati A.
    Cancer; 1997 Jun 25; 81(3):180-6. PubMed ID: 9196017
    [Abstract] [Full Text] [Related]

  • 5. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B.
    Cancer Res; 1994 Jun 01; 54(11):2852-5. PubMed ID: 8187067
    [Abstract] [Full Text] [Related]

  • 6. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL, Ghadimi BM, Wangsa D, Padilla-Nash H, Worrell R, Hewitt S, Walther M, Linehan WM, Klausner RD, Ried T.
    Genes Chromosomes Cancer; 2001 May 01; 31(1):1-9. PubMed ID: 11284029
    [Abstract] [Full Text] [Related]

  • 7. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 01; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 8. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC, Walsh S, Hewson K, Green EK, Brinke A, Green PM, Gianelli F, Eng C, Maher ER.
    Genes Chromosomes Cancer; 1999 Sep 01; 26(1):20-8. PubMed ID: 10441001
    [Abstract] [Full Text] [Related]

  • 9. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
    Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z.
    Am J Pathol; 1997 Oct 01; 151(4):951-6. PubMed ID: 9327728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
    Schraml P, Zhaou M, Richter J, Brüning T, Pommer M, Sauter G, Mihatsch MJ, Moch H.
    Verh Dtsch Ges Pathol; 1999 Oct 01; 83():218-24. PubMed ID: 10714214
    [Abstract] [Full Text] [Related]

  • 14. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K, Esumi M, Ishida H, Okada K.
    J Urol; 1999 Aug 01; 162(2):614-8. PubMed ID: 10411097
    [Abstract] [Full Text] [Related]

  • 15. Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology.
    Abati A, Sanjuan X, Wilder A, Linehan WM, Hewitt SM, Merino MJ.
    Cancer; 1999 Aug 25; 87(4):231-7. PubMed ID: 10455212
    [Abstract] [Full Text] [Related]

  • 16. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T, Sekine T, Tobisu K, Oshimura M, Yokota J.
    Jpn J Clin Oncol; 1993 Aug 25; 23(4):226-31. PubMed ID: 8105119
    [Abstract] [Full Text] [Related]

  • 17. Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma.
    Lee YS, Vortmeyer AO, Lubensky IA, Vogel TW, Ikejiri B, Ferlicot S, Benoît G, Giraud S, Oldfield EH, Linehan WM, Teh BT, Richard S, Zhuang Z.
    Clin Cancer Res; 2005 Feb 01; 11(3):1059-64. PubMed ID: 15709172
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM.
    Urol Clin North Am; 1993 May 01; 20(2):207-16. PubMed ID: 8098558
    [Abstract] [Full Text] [Related]

  • 19. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chrétien Y, Maréchal JM, Weissenbach J, Junien C.
    Genes Chromosomes Cancer; 1996 Dec 01; 17(4):215-24. PubMed ID: 8946203
    [Abstract] [Full Text] [Related]

  • 20. Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.
    Mochida J, Esumi M, Kitajima A, Okada K.
    J Urol; 2008 Aug 01; 180(2):724-8. PubMed ID: 18554638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.